Orajel Gum Pain Relief Gel 0.125oz Sku 903432 Good Sense Oral…
CGMP Deviations: product held outside appropriate storage temperature conditions.
Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,390 recalls, newest first.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations: product held outside appropriate storage temperature conditions.
cGMP - Water leakage
Superpotent Drug: Out of specification for assay at the 12-month timepoint.
Superpotent Drug: Out of specification for assay at the 12-month timepoint.
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Lack of Assurance of Sterility: Out-of-specification test results obtained for Endotoxin testing.